Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled Trial
This study is not yet open for participant recruitment.
Verified by Tata Memorial Hospital, March 2007
Sponsored by: Tata Memorial Hospital
Information provided by: Tata Memorial Hospital
ClinicalTrials.gov Identifier: NCT00447746
  Purpose

Gastric cancer remains the second most common cancer worldwide.Although the prognosis is poor for majority of patients , long term survival is achievable in patients in whom surgical resection is possible.

However the results of surgery are generally disapointing in most large series.The exception to this appears to be Japan and far east where a standardized approach to surgery is undertaken with low morbidity and mortality.The extent of surgery and particularly the development of systematic lymphadenectomy(D2)has been credited in Japan for the improved outcome in patients with gastric cancer.

Hence for comparing the difference between D1 and D2 lymphadenectomy for gastric cancer in terms of overall survival,disease free survival and loco regional recurrence and also post operative morbidity and mortality following both these procedures,this study has been undertaken.

In D1 lymphadenectomy, only those lymph nodes which are adjacent to the part of stomach being resected will be removed.In D2 lymphadenectomy other lymph nodes draining the stomach will also be removed according to internationally accepted guidelines and also include resection of greater omentum along with anterior layer of transverse mesocolon and lesser omentum upto its attachment to hepatoduodenal ligament.

Currently both these procedures are widely practised worldwide and there is no definite evidence showing the superiority of one procedure over the other.Neither is any of these procedures experimental.

We are doing this trial to see whether one of these procedures is superior to the other.


Condition Intervention
Gastric Cancer
Procedure: D1 or D2 lymphadenectomy for gastric cancer patients

MedlinePlus related topics: Cancer Stomach Cancer
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment
Official Title: A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled Trial

Further study details as provided by Tata Memorial Hospital:

Primary Outcome Measures:
  • 5 year overall survival

Secondary Outcome Measures:
  • : 5 year disease free survival
  • : 5 year local recurrence
  • : Postoperative morbidity and mortality rates

Estimated Enrollment: 600
Study Start Date: March 2007
Estimated Study Completion Date: March 2014
  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:Patients with biopsy/frozen section proven adenocarcinoma of stomach.

  • Preoperative clinical examination and imaging indicating operable disease.
  • Intraoperative exploration indicating operability i.e. no peritoneal deposits,no evidence of para aortic lymphadenopathy,no direct involvement of contiguous organs
  • Surgical plan for distal/proximal/total gastrectomy

Exclusion Criteria:Patients with low performance score

  • Staging investigations or intraoperative exploration indicating inoperable disease
  • Patients medically unfit for major surgery
  • Patients who have been given preoperative chemotherapy/chemoradiation.
  • Patients with gastroesophageal junction tumours
  • Patients unreliable for follow up
  • Patients above the age of 70 years
  • Past history of malignancy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00447746

Contacts
Contact: Dr Parul J Shukla, M.S.,FRCS +912224177172 pjshukla@hotmail.com
Contact: Dr Shailesh v Shrikhande, M.S. +912224177173

Locations
India, Maharashtra
Tata Memorial Hospital,Tata Memorial Centre
Mumbai, Maharashtra, India, 400012
Sponsors and Collaborators
Tata Memorial Hospital
Investigators
Principal Investigator: Dr Parul J Shukla, M.S.,FRCS Tata Memorial Centre,Mumbai
  More Information

Study ID Numbers: TMH 262
Study First Received: March 14, 2007
Last Updated: March 14, 2007
ClinicalTrials.gov Identifier: NCT00447746  
Health Authority: Hospital Scientific Committee,Tata Memorial Centre Mumbai,India:;   Hospital Ethics Committee Tata Memorial Centre Mumbai,India:

Keywords provided by Tata Memorial Hospital:
Comparison between D1 and D2 lymphadenectomy for gastric cancer

Study placed in the following topic categories:
Stomach Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Stomach Neoplasms
Gastrointestinal Neoplasms
Stomach cancer

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 16, 2009